Published in Case Reports Hepatol on April 10, 2016
RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci (2015) 1.45
Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol (2003) 1.34
Biological properties of baicalein in cardiovascular system. Curr Drug Targets Cardiovasc Haematol Disord (2005) 1.25
Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci (1995) 1.22
Hepatotoxicity associated with chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature. Pharmacotherapy (2010) 1.13
Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin Cancer Res (2005) 1.06
Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol (2015) 1.04
Pneumonitis induced by ou-gon (scullcap). Intern Med (2001) 1.04
Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol (2003) 1.00
Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine (2003) 1.00
Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Ann Hepatol (2014) 0.90
Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang. J Chin Med Assoc (2006) 0.89
Significant decrease of cyclosporine bioavailability in rats caused by a decoction of the roots of Scutellaria baicalensis. Planta Med (2004) 0.89
The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1. Clin Pharmacol Ther (2007) 0.89
Herbal hepatoxicity from Chinese skullcap: A case report. World J Hepatol (2012) 0.88
Chinese skullcap in move free arthritis supplement causes drug induced liver injury and pulmonary infiltrates. Case Reports Hepatol (2013) 0.82
Acute thrombocytopenic purpura after ingestion of Sho-saiko-to for hepatitis. Liver (2000) 0.79
Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir. Case Reports Hepatol (2015) 0.75